Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
October 15, 2024
Oleanolic acid 28-O-β-D-glucopyranoside: A novel therapeutic agent against ulcerative colitis via anti-inflammatory, barrier-preservation, and gut microbiota-modulation
Caixia Wang, Hanlin Liu, Zhuoqiao Li, et al.
Pharmaceuticals (Basel, Switzerland)
|
May 4, 2026
Development of Pseudoginsenoside RT2 as a Novel Gut-Selective Agent: Integrated Pharmacodynamic and Pharmacokinetic Evaluation of an Ocotillol Ginsenoside for Ulcerative Colitis
Zhuoqiao Li, Junzhe Wu, Jia Wang, et al.
Journal of Ethnopharmacology
|
August 8, 2025
Oleanolic acid 28-O-β-D-glucopyranoside alleviates TNBS-induced ulcerative colitis in rat by regulating Nrf2/x-CT/GPX4-mediated ferroptosis
Caixia Wang, Zhuoqiao Li, Linxuan Liu, et al.
Journal of Ethnopharmacology
|
June 16, 2026
Corrigendum to "Oleanolic acid 28-O-β-D-glucopyranoside alleviates TNBS-induced ulcerative colitis in rat by regulating Nrf2/x-CT/GPX4-mediated ferroptosis" [Journal of Ethnopharmacology 353 (2025) 120369]
Caixia Wang, Zhuoqiao Li, Linxuan Liu, et al.
Journal of Agricultural and Food Chemistry
|
September 25, 2025
Ginsenoside Rk2 Provides Multidimensional Relief for Ulcerative Colitis by Improving Intestinal Barrier Function, Reshaping Gut Microbiota, and Regulating Th17/Treg Balance
Luying Tan, Zhuoqiao Li, Junzhe Wu, et al.
International Journal of Molecular Sciences
|
January 23, 2024
Study on the Anti-Ulcerative Colitis Effect of Pseudo-Ginsenoside RT4 Based on Gut Microbiota, Pharmacokinetics, and Tissue Distribution
Hui Yu, Caixia Wang, Junzhe Wu, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology
|
March 27, 2024
Novel applications of Yinhua Miyanling tablets in ulcerative colitis treatment based on metabolomics and network pharmacology
Caixia Wang, Hui Yu, Zhuoqiao Li, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology
|
January 8, 2024
(-)-Syringaresinol attenuates ulcerative colitis by improving intestinal epithelial barrier function and inhibiting inflammatory responses
Yunhe Liu, Junzhe Wu, Luying Tan, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
March 25, 2022
Protective effect of total Saponins from American ginseng against cigarette smoke-induced COPD in mice based on integrated metabolomics and network pharmacology
Hongqiang Lin, Caixia Wang, Hui Yu, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology
|
June 15, 2026
Targeting barrier integrity: Pseudoginsenoside RT2 ameliorates ulcerative colitis by driving epithelial renewal via the Wnt/β-catenin pathway
Zhuoqiao Li, Luying Tan, Junzhe Wu, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
October 15, 2024
Oleanolic acid 28-O-β-D-glucopyranoside: A novel therapeutic agent against ulcerative colitis via anti-inflammatory, barrier-preservation, and gut microbiota-modulation
Caixia Wang, Hanlin Liu, Zhuoqiao Li, et al.
Pharmaceuticals (Basel, Switzerland)
|
May 4, 2026
Development of Pseudoginsenoside RT2 as a Novel Gut-Selective Agent: Integrated Pharmacodynamic and Pharmacokinetic Evaluation of an Ocotillol Ginsenoside for Ulcerative Colitis
Zhuoqiao Li, Junzhe Wu, Jia Wang, et al.
Journal of Ethnopharmacology
|
August 8, 2025
Oleanolic acid 28-O-β-D-glucopyranoside alleviates TNBS-induced ulcerative colitis in rat by regulating Nrf2/x-CT/GPX4-mediated ferroptosis
Caixia Wang, Zhuoqiao Li, Linxuan Liu, et al.
Journal of Ethnopharmacology
|
June 16, 2026
Corrigendum to "Oleanolic acid 28-O-β-D-glucopyranoside alleviates TNBS-induced ulcerative colitis in rat by regulating Nrf2/x-CT/GPX4-mediated ferroptosis" [Journal of Ethnopharmacology 353 (2025) 120369]
Caixia Wang, Zhuoqiao Li, Linxuan Liu, et al.
Journal of Agricultural and Food Chemistry
|
September 25, 2025
Ginsenoside Rk2 Provides Multidimensional Relief for Ulcerative Colitis by Improving Intestinal Barrier Function, Reshaping Gut Microbiota, and Regulating Th17/Treg Balance
Luying Tan, Zhuoqiao Li, Junzhe Wu, et al.
International Journal of Molecular Sciences
|
January 23, 2024
Study on the Anti-Ulcerative Colitis Effect of Pseudo-Ginsenoside RT4 Based on Gut Microbiota, Pharmacokinetics, and Tissue Distribution
Hui Yu, Caixia Wang, Junzhe Wu, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology
|
March 27, 2024
Novel applications of Yinhua Miyanling tablets in ulcerative colitis treatment based on metabolomics and network pharmacology
Caixia Wang, Hui Yu, Zhuoqiao Li, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology
|
January 8, 2024
(-)-Syringaresinol attenuates ulcerative colitis by improving intestinal epithelial barrier function and inhibiting inflammatory responses
Yunhe Liu, Junzhe Wu, Luying Tan, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
March 25, 2022
Protective effect of total Saponins from American ginseng against cigarette smoke-induced COPD in mice based on integrated metabolomics and network pharmacology
Hongqiang Lin, Caixia Wang, Hui Yu, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology
|
June 15, 2026
Targeting barrier integrity: Pseudoginsenoside RT2 ameliorates ulcerative colitis by driving epithelial renewal via the Wnt/β-catenin pathway
Zhuoqiao Li, Luying Tan, Junzhe Wu, et al.
Page
of 1